SIV infection and ARV treatment reshape the transcriptional and epigenetic profile of naïve and memory T cells in vivo
Journal of Virology · 2024
DOI: 10.1128/jvi.00283-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2024. Verfasst von Andrew R Rahmberg und 4 weiteren Autor:innen. Beteiligte Einrichtung: Barrier Immunity Section, Lab of Viral Diseases, NIAID, NIH, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Anti-Retroviral Agents, Epigenesis, Genetic, Memory T Cells, Simian Acquired Immunodeficiency Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, Intramural NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID).
Abstract (Originalsprache)
Human and simian immunodeficiency viruses (HIV and SIV) are lentiviruses that reverse transcribe their RNA genome with subsequent integration into the genome of the target cell. How progressive infection and administration of antiretrovirals (ARVs) longitudinally influence the transcriptomic and epigenetic landscape of particular T cell subsets, and how these may influence the genetic location of integration are unclear. Here, we use RNAseq and ATACseq to study the transcriptomics and epigenetic landscape of longitudinally sampled naïve and memory CD4+ and CD8+ T cells in two species of non-human primates prior to SIV infection, during chronic SIV infection, and after administration of ARVs. We find that SIV infection leads to significant alteration to the transcriptomic profile of all T cell subsets that are only partially reversed by administration of ARVs. Epigenetic changes were more apparent in animals with longer periods of untreated SIV infection and correlated well with changes in corresponding gene expression. Known SIV integration sites did not vary due to SIV status but did contain more open chromatin in rhesus macaque memory T cells, and the expression of proteasome-related genes at the pre-SIV timepoint correlated with subsequent viremia. IMPORTANCE Chronic inflammation during progressive human and simian immunodeficiency virus (HIV and SIV) infections leads to significant co-morbidities in infected individuals with significant consequences. Antiretroviral (ARV)-treated individuals also manifest increased levels of inflammation which are associated with increased mortalities. These data will help guide rational development of modalities to reduce inflammation observed in people living with HIV and suggest mechanisms underlying lentiviral integration site preferences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Barrier Immunity Section, Lab of Viral Diseases, NIAID, NIH, Bethesda, Maryland, USA.
- Integrated Data Sciences Section, Research Technologies Branch, NIAID, NIH, Bethesda, Maryland, USA.
- Division of Immunology, Tulane National Primate Research Center, Covington, Louisiana, USA.
- Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
ORCID-Profile: Andrew R Rahmberg, Jason M Brenchley
Förderung
- NIH HHS
- Intramural NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
Zitieren
APA
Rahmberg, A. R., Markowitz, T. E., Mudd, J. C., Ortiz, A. M., & Brenchley, J. M. (2024). SIV infection and ARV treatment reshape the transcriptional and epigenetic profile of naïve and memory T cells in vivo. Journal of Virology. https://doi.org/10.1128/jvi.00283-24
Vancouver
Rahmberg AR, Markowitz TE, Mudd JC, Ortiz AM, Brenchley JM. SIV infection and ARV treatment reshape the transcriptional and epigenetic profile of naïve and memory T cells in vivo. Journal of Virology. 2024. doi:10.1128/jvi.00283-24
BibTeX
@article{Rahmberg2024,
author = {Rahmberg, Andrew R and Markowitz, Tovah E and Mudd, Joseph C and Ortiz, Alexandra M and Brenchley, Jason M},
title = {SIV infection and ARV treatment reshape the transcriptional and epigenetic profile of naïve and memory T cells in vivo},
journal = {Journal of Virology},
year = {2024},
doi = {10.1128/jvi.00283-24}
}
EUVIMED